Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GDTC | US
0.05
2.41%
Healthcare
Biotechnology
31/03/2024
17/10/2024
2.13
2.16
2.16
2.10
CytoMed Therapeutics Limited a pre-clinical biopharmaceutical company focuses on developing novel cell-based immunotherapies for the treatment of human cancers in Malaysia and Singapore. Its lead product candidate is CTM-N2D which is in Phase I clinical trials comprising expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT which utilizes iPSC as a starting material to generate gdNKT a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT a product candidate that consists of expanded gamma delta T cells and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
69.5%1 month
63.5%3 months
78.1%6 months
70.9%-
-
3.03
0.04
0.04
-4.45
-
-
-3.12M
24.58M
24.58M
-
-735.97
-
-21.10
-26.26
40.28
6.97
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.44
Range1M
1.04
Range3M
1.15
Rel. volume
1.19
Price X volume
29.36K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 1.45 | 26.90M | -0.68% | n/a | 571.64% |
Akari Therapeutics Plc | AKTX | Biotechnology | 2.21 | 26.84M | -12.30% | n/a | -27.01% |
Common Stock | NRBO | Biotechnology | 3.16 | 26.82M | 6.76% | n/a | 0.90% |
PLUR | PLUR | Biotechnology | 4.8089 | 26.31M | -2.85% | n/a | 30845.83% |
SABS | SABS | Biotechnology | 2.76 | 25.47M | -11.25% | n/a | 11.58% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.1794 | 25.11M | 12.83% | n/a | 21.99% |
Iterum Therapeutics plc | ITRM | Biotechnology | 1.09 | 24.75M | 5.83% | n/a | -198.11% |
iBio Inc | IBIO | Biotechnology | 2.85 | 24.62M | 0.00% | n/a | 20.92% |
Caladrius Biosciences Inc | LSTA | Biotechnology | 2.94 | 24.46M | 0.00% | n/a | 0.58% |
Bolt Technology Corp | BOLT | Biotechnology | 0.638 | 24.41M | -0.31% | n/a | 22.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.45 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 3.03 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 78.09 | 72.92 | Par |
Debt to Equity | 0.04 | -1.24 | Expensive |
Debt to Assets | 0.04 | 0.25 | Cheaper |
Market Cap | 24.58M | 3.78B | Emerging |